KRYUKOV, Fedor, Pavel NĚMEC, Elena DEMENTYEVA, Lenka KUBICZKOVÁ, Ivana IHNATOVÁ, Eva BUDINSKÁ, Jiří JARKOVSKÝ, Sabina ŠEVČÍKOVÁ, Petr KUGLÍK and Roman HÁJEK. Molecular heterogeneity and centrosome-associated genes in multiple myeloma. Leukemia & Lymphoma. London: Taylor & Francis, 2013, vol. 54, No 9, p. 1982-1988. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2013.764416.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Molecular heterogeneity and centrosome-associated genes in multiple myeloma
Authors KRYUKOV, Fedor (643 Russian Federation, belonging to the institution), Pavel NĚMEC (203 Czech Republic, belonging to the institution), Elena DEMENTYEVA (643 Russian Federation, belonging to the institution), Lenka KUBICZKOVÁ (203 Czech Republic, belonging to the institution), Ivana IHNATOVÁ (703 Slovakia, belonging to the institution), Eva BUDINSKÁ (703 Slovakia), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Sabina ŠEVČÍKOVÁ (203 Czech Republic, belonging to the institution), Petr KUGLÍK (203 Czech Republic, belonging to the institution) and Roman HÁJEK (203 Czech Republic, guarantor, belonging to the institution).
Edition Leukemia & Lymphoma, London, Taylor & Francis, 2013, 1042-8194.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.605
RIV identification code RIV/00216224:14110/13:00065610
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3109/10428194.2013.764416
UT WoS 000323492400022
Keywords in English Multiple myeloma; centrosome abnormalities; gene expression profile
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 11/10/2013 13:45.
Abstract
In multiple myeloma (MM), biologic complexity originates from complex oncogenic processes involving somatic acquisition of myriad mutations coupled with genetic variability within the host. This pathogenically determined molecular heterogeneity predetermines clinical intricacy. In this study, we performed gene expression profi ling (GEP) focusing on centrosome-related genes to determine the molecular heterogeneity for centrosomeassociated genes in patients with MM. We identifi ed the gene pattern with an impact on myeloma pathogenesis. According to expression tendency, three subgroups of patients were established. The revealed molecular signature is related to overall survival as well as to clinical parameters and the International Staging System. Associations with integral clinical parameters allow us to proclaim the impact of the revealed functional gene set in MM genesis. We believe that future investigation of this molecular heterogeneity will help to refi ne the broad prognoses off ered by present-day established systems and even sub-stratify them.
Links
GAP304/10/1395, research and development projectName: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií
Investor: Czech Science Foundation
MSM0021622434, plan (intention)Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
NS10207, research and development projectName: Úloha abnormalit chromozómu 1 a kaskády NF-kappaB v patogenezi mnohočetného myelomu
Investor: Ministry of Health of the CR
NT11154, research and development projectName: Úloha mitotické disrupce v B lymfocytech u mnohočetném myelomu
Investor: Ministry of Health of the CR
NT13190, research and development projectName: Molekulární charakteristika centrozomálních abnormalit a jejich prognostický význam pro pacienty s mnohočetným myelomem
Investor: Ministry of Health of the CR
PrintDisplayed: 12/10/2024 23:00